IP Library Granted Patent US 10,240,025
Granted Patent B2
US 10,240,025 · App. 15/831,916 · Granted Mar 26, 2019

Compositions comprising estolide compounds and methods of making and using the same

Inventors: Jeremy Forest (Honolulu, HI); Jakob Bredsguard (Rancho Santa Margarita, CA); Travis Thompson (Anaheim, CA)
Assignee: Biosynthetic Technologies, LLC
C08K5/11B21J3/00C09K5/00C09K5/044C09K5/045C10M105/36C10M105/42C10M111/04C10M129/72C10M143/06C10M169/041C10M169/042C10M171/008C09K2205/12C09K2205/122C10M2205/026C10M2207/02C10M2207/042C10M2207/10C10M2207/28C10M2207/2825C10M2207/301C10M2223/04C10M2223/043C10N2220/022C10N2220/30C10N2220/301C10N2220/302C10N2220/303C10N2220/305C10N2220/306C10N2240/08C10N2240/30C10N2240/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,025
App. No.
15/831,916
Granted
Mar 26, 2019
Kind
B2
Abstract

Provided herein are compositions comprising at least one estolide compound of formula: in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 1; R 1 , independently for each occurrence, is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R 2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R 3 and R 4 , independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. Also provided are uses of the compositions described herein.

Claims (47)

1. A purified, optically active form of a compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 2 to 8;

y is, independently for each occurrence, an integer selected from 2 to 8;

n is 0;

R 1 is an unsubstituted C 1 -C 20 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is hydrogen,

wherein each fatty acid chain residue of the compound is unsubstituted.

2. The compound of claim 1 , wherein x is 3.

3. The compound of claim 2 , wherein y is 12.

4. The compound of claim 1 , wherein x is 7.

5. The compound of claim 4 , wherein y is 8.

6. The compound of claim 5 , wherein R 1 is an unsubstituted C 13 -C 17 alkyl.

7. The compound of claim 6 , wherein R 1 is saturated.

8. The compound of claim 7 , wherein R 1 is unbranched.

9. The compound of claim 5 , wherein R 1 is an unsubstituted C 15 alkyl that is unbranched.

10. The compound of claim 9 , wherein R 1 is saturated.

11. A composition comprising the compound of claim 10 and at least one additive.

12. The compound of claim 1 , wherein the compound is enantiomerically pure.

13. A composition comprising at least one optically-active estolide compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 2 to 8;

y is, independently for each occurrence, an integer selected from 2 to 8;

n is 0;

R 1 is an unsubstituted C 1 -C 20 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is hydrogen,

wherein each fatty acid chain residue of the compound is unsubstituted; and

at least one additive.

14. The composition of claim 13 , wherein the at least one additive is selected from an antioxidant, a surfactant, and a stability enhancer.

15. A composition comprising at least one compound of claim 1 , and at least one additive.

16. The composition of claim 15 , wherein the at least one additive selected from an antioxidant, a surfactant, or a stability enhancer.

17. A composition comprising at least one compound of claim 6 , and at least one additive.

18. The composition of claim 17 , wherein the at least one additive selected from an antioxidant, a surfactant, or a stability enhancer.

19. A method comprising:

providing first estolide compound of Formula I:

wherein

x is, independently for each occurrence, an integer selected from 2 to 8;

y is, independently for each occurrence, an integer selected from 2 to 8;

n is 0;

R 1 is an unsubstituted C 1 -C 20 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is hydrogen,

wherein each fatty acid chain residue of the compound is unsubstituted; and

resolving the first estolide compound to provide a second estolide compound having optical activity.

20. The method of claim 19 , wherein the first estolide compound comprises a racemate.

21. The method of claim 20 , wherein the second estolide compound is enantiomerically pure.

22. The method of claim 20 , wherein resolving the first estolide compound comprises the use of chiral chromatography.

23. The composition of claim 11 , wherein the at least one additive selected from an antioxidant, a surfactant, or a stability enhancer.

Continuity (11)
Continuation 15582317 · Apr 28, 2017
Continuation 14829468 · Aug 18, 2015
Continuation 14676516 · Apr 1, 2015
Continuation 14100469 · Dec 9, 2013
Continuation 13754775 · Jan 30, 2013
Continuation 13587120 · Aug 16, 2012
Continuation 13531923 · Jun 25, 2012
Continuation 13404903 · Feb 24, 2012
Provisional Application 61498499 · Jun 17, 2011
Provisional Application 61569046 · Dec 9, 2011
Related Publication 20180112060A1 · Apr 26, 2018